SPDR S&P Biotech ETF (XBI)

  • Loading...
#10

Best Fit Health/Biotechnology Funds ETFs

U.S. News evaluated 29 Health/Biotechnology Funds ETFs and 16 make our Best Fit list. Our list highlights the best passively managed funds for long-term investors. Rankings are assigned based on comparisons with Best Fit funds in this category.

How we identify Best Fit Funds

Best Fit Scorecard
Costs Good
Tracking Error Good
Bid/Ask Ratio Typical
Holdings Diversity Good

Fund Description

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Fund Snapshot Updated 04.21.2014

Previous Close $128.42 Expense Ratio 0.35%
YTD Return 1.07% Avg. 30-Day Volume 1,050,242
1-Year Return 21.1% Market Cap Loading...
Bid $128.47 Shares Outstanding 8,800,000
Ask $128.51 Dividends $0.51
Top 10 Holdings
Sarepta Therapeutics Inc (SRPT) 1.89%
Mannkind Corp (MNKD) 1.70%
Myriad Genetics Inc (MYGN) 1.65%
Repligen Corp (RGEN) 1.58%
Geron Corp (GERN) 1.58%
United Therapeutics Corp Del (UTHR) 1.52%
Alkermes Plc (ALKS) 1.52%
Exact Sciences Corp (EXAS) 1.47%
Celgene Corp (CELG) 1.45%
Arena Pharmaceuticals Inc (ARNA) 1.44%
% of Total Holdings 15.80%

Sector Breakdown

Geographic Breakdown

Best Fit Health/Biotechnology Funds

See full rankings for Health/Biotechnology Funds